The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Long term results of liver transplantation for Wilson's disease: Experience in France
Author information
1Centre National de Référence de la Maladie de Wilson/Fédération des Spécialités Digestives, Hôpital Édouard Herriot, Hospices Civils de Lyon, Lyon, France. Electronic address: olivier.guillaud@chu-lyon.fr.
2Centre National de Référence de la Maladie de Wilson/Fédération des Spécialités Digestives, Hôpital Édouard Herriot, Hospices Civils de Lyon, Lyon, France.
3Centre National de Référence de la Maladie de Wilson/Centre Hépato-Biliaire, Hôpital Paul Brousse, AP-HP, Villejuif, France; UMR 785, INSERM, France; UMR-S 785, Univ Paris-Sud, Villejuif, France; DHU Hepatinov, Villejuif, France.
4Service d'Hépatologie Pédiatrique, Hôpital Necker-Enfants Malades, AP-HP, Paris, France.
5Service de Chirurgie générale et Transplantation, Hôpital Hautefeuille, CHU Strasbourg, France.
6Service d'Hépatologie, Hôpital Jean Minjoz, CHU Besançon, France.
7Service d'Hépatologie, Hôpital Beaujon, AP-HP, Clichy, France.
8Service de Chirurgie, Hôpital Cochin, AP-HP, Paris, France.
9Service d'Hépatologie, Hôpital Henri Mondor, AP-HP, Créteil, France.
10Service d'Hépato-Gastroentérologie, Hôpital Claude Huriez, CHRU Lille, Lille, France.
11Service de Néphrologie-Hypertension artérielle-Dialyse-Transplantation, Hôpital Rangueil, CHU de Toulouse, France.
12Service de Chirurgie Hépatobiliaire et Digestive, Hôpital de Pontchaillou, CHU de Rennes, France.
13Service d'Hépatologie et de Gastroentérologie, Hôpital Pellegrin, Bordeaux, France.
14Fédération Médico-Chirurgicale des Maladies de l'Appareil Digestif, Hôpital Saint-Eloi, Montpellier, France.
15Service de Chirurgie Digestive, CHU Bretonneau, Tours, France.
16Service de Chirurgie Digestive, Hôpital L'Archet (2), CHU Nice, Nice, France.
17Centre National de Référence de la Maladie de Wilson/Service de Pédiatrie, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France.
18Centre National de Référence de la Maladie de Wilson/Service d'Hépatologie et de Transplantation Hépatique Pédiatriques, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France; DHU Hepatinov, Villejuif, France.
19Service d'Hépatologie, Hôpital de la Croix-Rousse, Hospices civils de Lyon, Lyon, France.
20Service de Chirurgie Digestive, Hôpital la Conception, Marseille, France.
21Service d'Hépatologie, Hôpital St Antoine, AP-HP, Paris, France.
22Centre National de Référence de la Maladie de Wilson/Service de Neurologie, Hôpital Lariboisière, AP-HP, Paris, France.
23Service de chirurgie hépatobiliaire et transplantation hépatique, Hôpital St Antoine, AP-HP, Paris, France.
Abstract
BACKGROUND & AIMS:
Liver transplantation (LT) is the therapeutic option for severe complications of Wilson's disease (WD). We aimed to report on the long-term outcome of WD patients following LT.
METHODS:
The medical records of 121 French patients transplanted for WD between 1985 and 2009 were reviewed retrospectively. Seventy-five patients were adults (median age: 29years, (18-66)) and 46 were children (median age: 14years, (7-17)). The indication for LT was (1) fulminant/subfulminant hepatitis (n=64, 53%), median age=16years (7-53), (2) decompensated cirrhosis (n=50, 41%), median age=31.5years (12-66) or (3) severe neurological disease (n=7, 6%), median age=21.5years (14.5-42). Median post-transplant follow-up was 72months (0-23.5).
RESULTS:
Actuarial patient survival rates were 87% at 5, 10, and 15years. Male gender, pre-transplant renal insufficiency, non elective procedure, and neurological indication were significantly associated with poorer survival rate. None of these factors remained statistically significant under multivariate analysis. In patients transplanted for hepatic indications, the prognosis was poorer in case of fulminant or subfulminant course, non elective procedure, pretransplant renal insufficiency and in patients transplanted before 2000. Multivariate analysis disclosed that only recent period of LT was associated with better prognosis. At last visit, the median calculated glomerular filtration rate was 93ml/min (33-180); 11/93 patients (12%) had stage II renal insufficiency and none had stage III.
CONCLUSIONS:
Liver failure associated with WD is a rare indication for LT (<1%), which achieves an excellent long-term outcome, including renal function.